Objectives: Oxidative stress caused by acute hyperhomocysteinemia impairs endothelial function in human arteries. We sought to identify markers of endothelial dysfunction during methionine-induced hyperhomocysteinemia. Design and methods: 35 subjects underwent flow-mediated dilation (FMD) of the brachial artery by high-resolution ultrasonography and fasting blood samples before and 3 h postmethionine load (PML). Clinical, conventional biochemical, and redox status (plasma total and reduced homocysteine, glutathione, cysteine, cysteinylglycine, ascorbic acid, α-tocopherol, free malondialdehyde, blood glutathione) data were sequentially entered into an univariate and multivariate stepwise linear regression analysis to evaluate their relation ...
BACKGROUND AND OBJECTIVE: Coronary slow-flow (CSF) phenomenon is characterized by delayed opacificat...
This review discussed and in particular emphasis the potential cellular pathways and the biological ...
Homocysteine (Hcy) is a sulfur-containing non-proteinogenic amino acid formed during the metabolism ...
Background—Elevated plasma homocysteine is a risk factor for arteriosclerosis, but a cause-and-effec...
OBJECTIVE: Homocysteinemia is associated with elevated oxidative stress and impaired endothelial fun...
Dysfunction of the endothelium is an early event in the pathophysiology of atherosclerosis. Elevated...
OBJECTIVES: Endothelin-1 (ET-1) is a key regulator of arterial blood pressure in humans, and homocys...
OBJECTIVE: The aim of the study was to evaluate the effects of acute hyperhomocysteinemia on distens...
Background: Homocysteine is a sulfur-containing intermediate product in the normal metabolism of met...
Context: Increased levels of homocysteine are associated with risk of cardiovascular disease. Homocy...
Background and Objective: Coronary slow-flow (CSF) phenomenon is characterized by delayed opacificat...
Hyperhomocysteinemia is a risk factor for vascular disease, although its mechanism of action is not ...
OBJECTIVE: To explore to what extent homocysteine, S-adenosylmethionine (SAM), S-adenosylhomocystein...
Objective - To explore to what extent homocysteine, S-adenosylmethionine (SAM), S-adenosylhomocystei...
Objective - To explore to what extent homocysteine, S-adenosylmethionine (SAM), S-adenosylhomocystei...
BACKGROUND AND OBJECTIVE: Coronary slow-flow (CSF) phenomenon is characterized by delayed opacificat...
This review discussed and in particular emphasis the potential cellular pathways and the biological ...
Homocysteine (Hcy) is a sulfur-containing non-proteinogenic amino acid formed during the metabolism ...
Background—Elevated plasma homocysteine is a risk factor for arteriosclerosis, but a cause-and-effec...
OBJECTIVE: Homocysteinemia is associated with elevated oxidative stress and impaired endothelial fun...
Dysfunction of the endothelium is an early event in the pathophysiology of atherosclerosis. Elevated...
OBJECTIVES: Endothelin-1 (ET-1) is a key regulator of arterial blood pressure in humans, and homocys...
OBJECTIVE: The aim of the study was to evaluate the effects of acute hyperhomocysteinemia on distens...
Background: Homocysteine is a sulfur-containing intermediate product in the normal metabolism of met...
Context: Increased levels of homocysteine are associated with risk of cardiovascular disease. Homocy...
Background and Objective: Coronary slow-flow (CSF) phenomenon is characterized by delayed opacificat...
Hyperhomocysteinemia is a risk factor for vascular disease, although its mechanism of action is not ...
OBJECTIVE: To explore to what extent homocysteine, S-adenosylmethionine (SAM), S-adenosylhomocystein...
Objective - To explore to what extent homocysteine, S-adenosylmethionine (SAM), S-adenosylhomocystei...
Objective - To explore to what extent homocysteine, S-adenosylmethionine (SAM), S-adenosylhomocystei...
BACKGROUND AND OBJECTIVE: Coronary slow-flow (CSF) phenomenon is characterized by delayed opacificat...
This review discussed and in particular emphasis the potential cellular pathways and the biological ...
Homocysteine (Hcy) is a sulfur-containing non-proteinogenic amino acid formed during the metabolism ...